While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated its earnings and revenue guidance for the full-year 2026, in line with analysts' estimates.For fiscal 2026, the company now projects earnings in a range of $14.29 to$14.80 per share on revenues between $4.632 billion and$4.720 billion, with revenue growth of 7.6 to 9.6 percent and organic revenue growth of 7 to 9 percent.On average, analysts polled expect the company to re ...